| Autor: |
Edgar JM; Institute of Comparative Medicine, University of Glasgow, Scotland, UK. j.edgar@vet.gla.ac.uk, McCulloch MC, Montague P, Brown AM, Thilemann S, Pratola L, Gruenenfelder FI, Griffiths IR, Nave KA |
| Jazyk: |
angličtina |
| Zdroj: |
EMBO molecular medicine [EMBO Mol Med] 2010 Feb; Vol. 2 (2), pp. 42-50. |
| DOI: |
10.1002/emmm.200900057 |
| Abstrakt: |
It is widely thought that demyelination contributes to the degeneration of axons and, in combination with acute inflammatory injury, is responsible for progressive axonal loss and persistent clinical disability in inflammatory demyelinating disease. In this study we sought to characterize the relationship between demyelination, inflammation and axonal transport changes using a Plp1-transgenic mouse model of Pelizaeus-Merzbacher disease. In the optic pathway of this non-immune mediated model of demyelination, myelin loss progresses from the optic nerve head towards the brain, over a period of months. Axonal transport is functionally perturbed at sites associated with local inflammation and 'damaged' myelin. Surprisingly, where demyelination is complete, naked axons appear well preserved despite a significant reduction of axonal transport. Our results suggest that neuroinflammation and/or oligodendrocyte dysfunction are more deleterious for axonal health than demyelination per se, at least in the short term. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Plný text